OneMedNet Reports $18.76 Million in Bookings Since the Start of 2026
Key Facts
OneMedNet said contractual bookings since the start of 2026 totaled about $18.76 million as of November 6, a rise that puts the company’s ability to convert contracts into actual revenue to the test. The company said bookings amount to about 14 times the total recorded during fiscal 2025. But it reported that only $1.388 million of bookings had converted to revenue through September 30. The bookings measurement date differs from the revenue date: the former extends through November, while the latter stops at the end of the third quarter. The significance of the contractual figure therefore depends on how quickly agreements are implemented and customers accept the delivered data.
The company’s contract performance shows activity accelerating compared with the previous year, when total bookings reached $2.79 million, more than four times 2024 bookings. On September 18, the company said bookings since the start of the year had reached about $16.2 million, 16 times the level for the same period in 2025, and that a large portion was expected to be delivered during the rest of the year. In a November 6 update, the company estimated preliminary third-quarter revenue at about $1 million. It said that represented an increase of 242% from the second quarter and 465% from the comparable period in 2025. These figures show reported growth in quarterly revenue, but do not mean the full value of bookings has become recognized revenue.
The chief executive said the growth was linked to building relationships with companies that have contracts in pharmaceuticals and foundational AI, as well as streamlining contracting and shortening the time needed to record a booking. He added that the platform can deliver multimodal data at the required scale, describing one operational change as: "Simplifying the contracting process and reducing the time until a booking is recorded." In September, the company said platform improvements had increased order fulfillment speed by about 50 times, accelerating the preparation and delivery of datasets. On November 3, it also announced that a customer had exercised an expansion option under a multi-year agreement, increasing the contracted data volume by 150% to support a derived data product the customer plans to sell. The following day, it announced a mid-value repeat order from a company developing AI models for radiology, after delivering the first dataset to the customer.
OneMedNet says about half of its 2026 contracts were signed with new customers, indicating that the increase in bookings included customer acquisition as well as expansion of existing agreements. According to its statement, its network includes more than 2,300 sites, more than 90 million patient journeys and 270 million studies. One of its multi-year agreements also includes an option to expand data volume and contract value, with sublicensing revenue available when the solution is licensed to end users. These figures are based on a model of selling datasets and related services, while revenue recognition requires delivery and acceptance, according to the company. The company cautioned that there is no guarantee bookings will convert to recognized revenue at the expected values or within the expected timeframe.
The company forecast revenue of between $12 million and $14 million in the fourth quarter of 2026, linking the estimate to expected customer acceptance of delivered data. The forecast is a near-term test of its ability to convert accumulated bookings into revenue, following its preliminary estimate of about $1 million in third-quarter revenue. It said it expects to issue its quarterly 10-Q report for the period ended September 30 by November 16, 2026. In the stock market, OneMedNet shares closed at $5.14 on November 6, compared with a close of $4.17 on November 5. The share move came in the session before the bookings update published on November 9 and does not by itself establish a market reaction to that announcement.